Key facts
- Better MedTech’s last known valuation is $64.9M (Jan 2024).
- It has raised $14.1M; the latest was Early Stage VC in Apr 2025.
- Notable investors include Vision Plus Capital, China Growth Capital, Lotus Lake Ventures, CDBI Partners, Everest VC — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Better MedTech
- ·The full record, as it builds
Funding rounds
No funding rounds for Better MedTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Better MedTech
Manufacturer of medical equipment intended for hospitals, specialty clinics, and healthcare providers. The company is engaged in the design, R&D, manufacturing, and sales of medical devices, thereby enabling customers to access innovative, reliable, specialty-focused medical instrument solutions that enhance clinical precision and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- bettermedtech.com/
- Ownership
- Privately Held (backing)
Better MedTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Better MedTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Better MedTech in its N-PORT filings yet. We sweep new filings monthly.